TH
MDCO

Timber Hill’s Medicines Co MDCO Stock Holding History

Timber Hill’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-6,476
Closed -$288K – 2008
2017
Q1 		$317K Buy
+6,476
New +$295K ﹤0.01% 1731
2014
Q1 		– Sell
-9,696
Closed -$321K – 3094
2013
Q4 		$374K Sell
9,696
-12,705
-57% -$454K ﹤0.01% 2494
2013
Q3 		$751K Buy
+22,401
New +$714K ﹤0.01% 2156

Other funds holding MDCO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
AH
Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Timber Hill's MDCO Position: Q2 2017 in Review

Timber Hill sold out of Medicines Co (MDCO) in Q2 2017, closing a stake of 6,476 shares — an estimated $288K sold.

Timber Hill first reported a position in MDCO in Q3 2013 and held it in 3 quarters. The position peaked at $751K in Q3 2013. 202 funds tracked by Wall St. Rank hold MDCO as of Q2 2017.

  • Timber Hill reported no remaining Medicines Co position as of Q2 2017 after selling out during the quarter.
  • Timber Hill sold 6,476 Medicines Co shares in Q2 2017, an estimated $288K.
  • Timber Hill first reported a position in Medicines Co in Q3 2013 and held it in 3 quarters.
  • Timber Hill's Medicines Co position peaked at $751K in Q3 2013.
  • 202 funds tracked by Wall St. Rank held Medicines Co as of Q2 2017.

Based on Timber Hill's 13F filing for Q2 2017, filed 9 Aug 2017.